Assignee
THERAVANCE INC
US272 patents
Top patents by PatentIndex Score
US7288657B2Oct 30, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC71 citations99
US6693202B1Feb 17, 2004
Muscarinic receptor antagonists
THERAVANCE INC253 citations99
US6653323B2Nov 25, 2003
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC100 citations99
US6576793B1Jun 10, 2003
β2-adrenergic receptor agonists
THERAVANCE INC115 citations99
US6541669B1Apr 1, 2003
β2-adrenergic receptor agonists
THERAVANCE INC114 citations99
US7879896B2Feb 1, 2011
Dual-acting imidazole antihypertensive agents
THERAVANCE INC53 citations98
US7345060B2Mar 18, 2008
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC63 citations98
US7265133B2Sep 4, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC65 citations98
US7141671B2Nov 28, 2006
Biphenyl derivatives
THERAVANCE INC145 citations98
US6747043B2Jun 8, 2004
Alkoxy aryl β2 adrenergic receptor agonists
THERAVANCE INC77 citations98
US6670376B1Dec 30, 2003
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC129 citations98
US6656694B2Dec 2, 2003
Method for identifying a ligand for a biological substrate
THERAVANCE INC88 citations98
US6635764B2Oct 21, 2003
Therapeutic ureas
THERAVANCE INC149 citations98
US6635618B2Oct 21, 2003
Glycopeptide phosphonate derivatives
THERAVANCE INC69 citations97
US8053448B2Nov 8, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations96
US8034946B2Oct 11, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC28 citations96
US8017783B2Sep 13, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC17 citations96
US8013005B2Sep 6, 2011
Dual-acting antihypertensive agents
THERAVANCE INC42 citations96
US7910608B2Mar 22, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations96
US7803812B2Sep 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC19 citations96
US7700777B2Apr 20, 2010
Crystalline forms of a biphenyl compound
THERAVANCE INC42 citations96
US7655621B2Feb 2, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC26 citations96
US7649080B2Jan 19, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC24 citations96
US7601690B2Oct 13, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC25 citations96
US7585879B2Sep 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC35 citations96
US7560469B2Jul 14, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7550595B2Jun 23, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7524959B2Apr 28, 2009
Biphenyl derivatives
THERAVANCE INC36 citations96
US7524965B2Apr 28, 2009
Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC44 citations96
US7521561B2Apr 21, 2009
Biphenyl derivatives
THERAVANCE INC36 citations96
US7521041B2Apr 21, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC27 citations96
US7514558B2Apr 7, 2009
Biphenyl derivatives
THERAVANCE INC32 citations96
US7507751B2Mar 24, 2009
Biphenyl derivatives
THERAVANCE INC33 citations96
US7491736B2Feb 17, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations96
US7456199B2Nov 25, 2008
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC49 citations96
US7375114B2May 20, 2008
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC41 citations96
US7355046B2Apr 8, 2008
Biphenyl derivatives
THERAVANCE INC42 citations96
US7345175B2Mar 18, 2008
Biphenyl derivatives
THERAVANCE INC49 citations96
US7341993B2Mar 11, 2008
Cross-linked glycopeptide—cephalosporin antibiotics
THERAVANCE INC22 citations96
US7279458B2Oct 9, 2007
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC50 citations96
US7262205B2Aug 28, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC50 citations96
US7208471B2Apr 24, 2007
Glycopeptide phosphonate derivatives
THERAVANCE INC24 citations96
US6974797B2Dec 13, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC45 citations96
US6887976B2May 3, 2005
Glycopeptide phosphonate derivatives
THERAVANCE INC24 citations96
US6878686B2Apr 12, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC49 citations96
US6872701B2Mar 29, 2005
Glycopeptide phosphonate derivatives
THERAVANCE INC23 citations96
US6713651B1Mar 30, 2004
β2-adrenergic receptor agonists
THERAVANCE INC49 citations96
US6593497B1Jul 15, 2003
β2-adrenergic receptor agonists
THERAVANCE INC56 citations96
US7858583B2Dec 28, 2010
Process for purifying glycopeptide phosphonate derivatives
THERAVANCE INC92 citations95
US7067481B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC41 citations95
Showing the top 50 of 272 patents by PatentIndex Score.